Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Study finds cetuximab maintenance may benefit some colorectal cancer patients after initial treatment
Study evaluates quizartinib plus chemotherapy for relapsed/refractory acute myeloid leukemia with FLT3 mutations
Study shows zinc supplements decrease severe hand-foot skin reactions from regorafenib cancer drug